Biomarkers in critical illness: have we made progress? - Wikidata - awgldk - TriplyDB

Biomarkers in critical illness: have we made progress?

Biomarkers in critical illness: have we made progress?

http://www.wikidata.org/entity/Q28077254

about

Increased DCLK1 correlates with the malignant status and poor outcome in malignant tumors: a meta-analysis.

P2860

Q47136464-18D1261A-4C34-4566-882E-412C805EF995

P2860

Biomarkers in critical illness: have we made progress?

http://www.wikidata.org/entity/Q28077254

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Biomarkers in critical illness: have we made progress?

@ast

Biomarkers in critical illness: have we made progress?

@en

Biomarkers in critical illness: have we made progress?

@nl

type

label

Biomarkers in critical illness: have we made progress?

@ast

Biomarkers in critical illness: have we made progress?

@en

Biomarkers in critical illness: have we made progress?

@nl

prefLabel

Biomarkers in critical illness: have we made progress?

@ast

Biomarkers in critical illness: have we made progress?

@en

Biomarkers in critical illness: have we made progress?

@nl

P1433

Q28077254-3F1CD976-1A8A-4A4F-A1D8-DF035BC0B09B

P1476

Q28077254-DAFF68EB-8809-4E8B-904C-95DCB5F5FD8B

P2093

Q28077254-2CAC57A4-5088-4298-98D6-0E7CF7B8F1E7

Q28077254-8380E30E-F021-47B3-9CDB-B4C5815792B0

Q28077254-EA273BF9-EAD0-4CC0-A181-86CB8E83ACEF

Q28077254-F56A835F-9425-4CA6-AAC5-2DA3C6923F3C

Q28077254-F5C3D6A5-734B-44FD-BE01-DC619E9BC9B1

Q28077254-F8CC8D9A-D34C-42FC-BE1A-97622907BD30

Q28077254-FD857377-2D68-41ED-9506-AFEF1D7406FC

P2860

Q28077254-16C40455-28D4-4FF5-812F-FA767D785D7A

Q28077254-1B11C10E-9663-4DC2-9E78-F14CFC41E3A1

Q28077254-2494E719-5B56-4435-B0A0-A960DAEA6B57

Q28077254-2B81BFD0-23CD-479E-B394-EF2995BAC891

Q28077254-35DD5E90-3CEA-4E5D-879D-CE089AF7ADE6

Q28077254-3B70C4A6-D1D0-4DEA-BD05-5A03A98D6693

Q28077254-42EEE8CD-69EB-4CAF-BD54-512E13839BC2

Q28077254-4C3A492C-58F4-480F-8323-BEBD79B6D9C8

Q28077254-725CD898-A847-452F-92F9-1CDD800951C7

Q28077254-792C9A78-99D6-42B4-9A66-F0509510EF80

P304

Q28077254-CA552D7E-8F36-409F-BC0E-6AB17A02C04F

P31

Q28077254-8C0F2C90-CD1E-43FC-9A26-7FB233C4FB66

P3181

Q28077254-99C4A406-12B7-4FF3-9ADB-E33BB413C89B

P356

Q28077254-CD63C2CB-4F21-46E0-8750-3CEDEB15158F

P407

Q28077254-58862FC4-7634-4AAD-A422-C58AA8F0F2C8

P478

Q28077254-15275459-2D54-46D3-AFD3-F02E3C33AFB4

P50

Q28077254-29847DE3-6039-4137-B87D-337730CA27A6

Q28077254-EA40D784-D72D-46B9-ADFB-80EC0319310B

P577

Q28077254-21DCB0DB-92E3-4CC4-9DDB-72BD0BBFC500

P698

Q28077254-7E9C05E5-D1D2-4AC7-882B-2274693B286F

P921

Q28077254-8B830B1B-8D2E-47CC-AEFB-DD61D7FE152B

P932

Q28077254-8922940C-3F98-410B-83EC-A989145A7497

P3181

P356

P1433

International Journal of Nephrology and Renovascular Disease

P1476

Biomarkers in critical illness: have we made progress?

@en

P2093

Elisabeth De Waele

http://www.w3.org/2001/XMLSchema#string

Inne Hendrickx

http://www.w3.org/2001/XMLSchema#string

Jouke De Regt

http://www.w3.org/2001/XMLSchema#string

Olivier Joannes-Boyau

http://www.w3.org/2001/XMLSchema#string

Patrick M Honore

http://www.w3.org/2001/XMLSchema#string

Rita Jacobs

http://www.w3.org/2001/XMLSchema#string

Willem Boer

http://www.w3.org/2001/XMLSchema#string

P2860

High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury.

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury

Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome

The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.

Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.

Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.

'Biomarking' infection during continuous renal replacement therapy: still relevant?

Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography

Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.

P304

253-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2950975

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/IJNRD.S113219

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27799811

http://www.w3.org/2001/XMLSchema#string

P921

P932

5074734

http://www.w3.org/2001/XMLSchema#string